Details for 2014766301

Up to date per 23.04.2026

Actions

Title / Product Name

KOMBINATION VON ALK- UND CDK-HEMMERN ZUR BEHANDLUNG ZELLPROLIFERATIVER ERKRANKUNGEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2014766301

EP Publication Number

3038652

E-Number

980349

Language

PCT Number

US14053244

Publication Date

06.07.2016 A

21.03.2018 B1

Registration Date

21.03.2018

AT Publication Date

15.04.2018

Application Date

28.08.2014

Registration Number

Priorities

28.08.2013

201361871275 P

IPC

A61K 31/506 20060101AFI20170406BHEP

Maximum Duration of Protection

28.08.2034

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

HARRIS, Jennifer LeslieNovartis Institute for Functional Genomics Inc. dba Genomics Institute of the Novartis Research Foundation 10675 John Jay Hopkins Drive San Diego, California 92121US

LI, NanxinNovartis Insitute for Functional Genomics Inc. dba Genomics Institute of the Novartis Research Foundation 10675 John Jay Hopkins Drive San Diego, California 92121US

SMITH, Timothy R.Novartis Institute for Functional Genomics Inc. dba Genomics Institute of theNovartis Research Foundation 10675 John Jay Hopkins Drive San Diego, California 92121US